Sato Pharmaceutical Co., Ltd

Form 483 issued October 25, 2019 · Hachioji, Japan

Inspection
Oct 17 – Oct 25, 2019
Investigator
Jason R. Caballero
Observations
8
Pages
6
FEI number
3004055563

In short: On October 25, 2019, FDA issued a Form 483 with 8 observations to Sato Pharmaceutical Co., Ltd in Hachioji, Tokyo (FEI 3004055563) after an inspection that ran Oct 17 – Oct 25, 2019. The investigator was Jason R. Caballero. Most observations concern facilities & equipment and laboratory controls.

At a glance

Facilities & equipment and laboratory controls account for 5 of 8 observations.

Facilities & equipment4
Laboratory controls1
Quality system1
Materials1
Other1

What FDA observed

Preview: the opening words of each observation
  1. 01

    Equipment and utensils are not cleaned and maintained at appropriate intervals to prevent contamination that would…

  2. 02

    Routine inspection and checking of automatic and electronic equipment is not performed according to a written…

  3. 03

    Established standards and laboratory control mechanisms are not followed. Electronic records are used, but they do…

  4. 04

    There is a failure to thoroughly review any unexplained discrepancy whether or not the batch…

4 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Sato Pharmaceutical Co., Ltd?

FDA listed 8 observations on this Form 483, mostly about facilities & equipment, laboratory controls and quality system. The opening words of each observation are shown on this page.

Who inspected Sato Pharmaceutical Co., Ltd?

Jason R. Caballero is named on this Form 483, for the inspection of Oct 17 – Oct 25, 2019. Each investigator has a profile showing what they cite most.

When was Sato Pharmaceutical Co., Ltd inspected by FDA?

The inspection ran Oct 17 – Oct 25, 2019, and the Form 483 is dated October 25, 2019.

How do I get the full Form 483 for Sato Pharmaceutical Co., Ltd?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free